跳至主要内容
临床试验/NL-OMON56974
NL-OMON56974尚未招募不适用

eedle-knife fistulotomy (NKF) for primary biliary access in patients with choledocholithiasis; a *real world* prospective multicenter pilot study - INCISIO

Amsterdam UMC0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with an indication for ERCP with sphincterotomy (e.g.
  • choledocholithiasis)
  • - Sedation with administration of propofol or general anesthesia during ERCP
  • - Naive papilla
  • - Capable of written informed consent
  • - Age >= 18 years

排除标准

  • - Low risk of pancreatitis: (1) definite chronic pancreatitis according to
  • M-ANNHEIM criteria
  • (15), (2) previous sphincterotomy, and (3) routine biliary stent exchange. In
  • case of a pancreatic duct intervention, chronic pancreatitis and previous
  • sphincterotomy are not exclusion criteria
  • - Acute pancreatitis, according to the Atlanta classification
  • - Altered anatomy (defined as anatomical variations in which bile and/or
  • pancreatic secretions (in case of pancreatic duct interventions) do not enter
  • the duodenum by way of the ampulla of Vater (e.g., Roux-en-Y reconstruction,
  • surgery for chronic pancreatitis)
  • - Pregnancy
  • - Severe liver disease (ascites)
  • - Contraindications for rectal NSAIDs, including allergy, active
  • gastrointestinal bleeding, ulcer disease, renal insufficiency (glomerular
  • filtration rate < 30 mL/min) and NSAID use for other indications (other than
  • cardioprotective aspirin)
  • - Coagulopathy or anticoagulant use, except for antiplatelet monotherapy
  • - Type I (flat papilla without oral protrusion) and type IIIA (papillary
  • orifice inside the diverticulum) according to the Viana classification (18),
  • and all others without an intraduodenal segment
  • - Active cholangitis

研究者

发起方
Amsterdam UMC

相似试验